SYNGENE

Syngene International Limited

Healthcare Research, Analytics & Technology

India's first Contract Research Organization, Syngene provides integrated drug discovery, development, and manufacturing services through a single platform known as CRAMS. Established in 1993 as a Biocon subsidiary, the company operates extensive research and manufacturing facilities spanning multiple locations across the country. It serves global pharmaceutical and biotechnology clients with end-to-end solutions, from early-stage research through commercial-scale production.

Investors holding Syngene International Limited

Nippon India Mutual Fund

Mutual Fund

7.73%

DSP Mutual Fund

Mutual Fund

4.61%

Government of Singapore

Foreign Investor

2.13%

SBI Mutual Fund

Mutual Fund

1.95%

Government Pension Fund Global (Norway)

Foreign Investor

1.82%

LIC

Institution

1.78%

HSBC Mutual Fund

Mutual Fund

1.55%

Latest move